PE1690, by Emma Shorter, calls for a review of support for people with ME with a view to investing in biomedical research, creating a centre of excellence for ME, ensuring that healthcare professionals’ training and education materials reflect the latest scientific evidence, providing specialist care for patients and discontinuing graded exercise therapy and cognitive behavioural therapy, which the petition refers to as harmful treatments.
We previously considered the petition in January, when we took evidence from the Cabinet Secretary for Health and Sport and the chief medical officer. The cabinet secretary subsequently provided a written submission that reiterated the Government’s commitment to ensuring that people with ME can access the best possible care and support. She added that the Government would work with others to explore ways in which the level of research could be increased and would set up a short-life working group made up of relevant stakeholders and people with lived experience to
“explore the provision of services and different practices across the country.”
The cabinet secretary also acknowledges the need to increase awareness and understanding among health professionals and states that the Government will continue to work with representative groups, including #MEAction Scotland and Action for ME, to that end.
10:15
The petitioner has argued that the continuing use of CBT and GET goes against the fundamental medical principle of doing no harm; indeed, along with others who have provided written submissions to the committee throughout our consideration of the petition, she argues strongly that CBT and GET are harmful.
In their submissions, the petitioner and Lesley Scott also query whether the research that led to the recommendation that CBT and GET be used as treatments for people with ME included any people with ME in the research cohort. In particular, the petitioner notes the position of the US Agency for Healthcare Research and Quality, which considered that there was
“a high risk of patients with other fatiguing illnesses”
being included in that cohort. That position is supported in a submission by Mr Stuart Brown, who asks why the national advisory committee for neurological conditions has not reported on the care of people with ME and suggests that there is an urgent need
“to commission research to establish the prevalence and burden of ME”.
The petitioner also raises concerns about the issue of informed consent, referring to the need for choice without coercion and arguing that
“treatment is often forced on children with ME using child protection laws”.
The submissions from Lesley Scott and an anonymous respondent appear to strongly support the petitioner’s argument. Moreover, in his submission, Mr Brown sets out concerns about the suitability of GET as a treatment and considers that the petitioner’s case for withdrawing that treatment is “indisputable”.
Members might recall that, at general question time on 22 May, the Minister for Public Health, Sport and Wellbeing responded to a question from Maureen Watt on behalf of a constituent who was concerned about ME not being included in the Scottish Government’s draft neurological plan. Mr FitzPatrick clarified that the national action plan for neurological conditions was not condition specific and that it covered all conditions, including ME. He added that the responses to the recent public consultation were currently being reviewed and that the Government would
“take on board the feedback that we have received and endeavour to ensure that the final plan is clear, throughout its intent and scope, that it is for all neurological conditions, including ME.”—Official Report, 22 May 2019; c 61.
Furthermore, in response to a supplementary question from Miles Briggs on how levels of funding for research into ME might be increased, the minister said that the Government frequently meets a range of stakeholders and that it would be willing to discuss the issue at its next meeting with stakeholders.
Do members have any comments or suggestions for action?
